Merck is preparing for the potential U.S. launch of an oncology mRNA-based individualized neoantigen therapy for early stage melanoma, which involves operational complexities for treatment sites and requires close coordination with cross-functional partners.
To ensure site readiness and consistent site execution, we are building a dedicated team of field-based operational roles to educate treatment sites on the practical, logistical, and operational requirements necessary to onboard the product.
#J-18808-LjbffrOncology Site Operations Lead - Southwest in augusta at Unknown Company
This position is listed as full time and onsite.